The study found that 10–27% of patients with NMO had negative serum AQP4-IgG, but a large proportion (42%) of these patients with negative serum AQP4-IgG could detect MOG antibodies, especially in patients with recurrent optic neuritis (Hamid et al., 2017). Here, AQP4 is linked to neuromyelitis optica.